UNII 4J9FJ0HL51

POTASSIUM PHOSPHATE, MONOBASIC

Unique Ingredient Identifier 4J9FJ0HL51 is listed as a ingredient substance

• RN: 7778-77-0
• EC: 231-913-4
• NCIT: C61900
• RXCUI: 55019
• MF: K.H2O4P
• INCHI KEY: GNSKLFRGEWLPPA-UHFFFAOYSA-M
• SMILES: [K+].OP(O)([O-])=O

Dosage Forms

UNII 4J9FJ0HL51 POTASSIUM PHOSPHATE, MONOBASIC is commonly included in medications in the following forms.

Route	Dosage Form	Potency
AN,INFILTRATION	INJECTION	2.72 %
AURICULAR (OTIC)	SOLUTION	0.2 %
IM - IV	INJECTION	0.096 %
INTRA-ARTICULAR	INJECTION	0.3 %
INTRAMUSCULAR	INJECTABLE	0.096 %W/V
INTRAMUSCULAR	INJECTION	0.3 %W/V
INTRAUTERINE	SOLUTION	NA
INTRAVENOUS	INJECTABLE	0.096 %
INTRAVENOUS	INJECTION	68 MG/VIAL
INTRAVENOUS	INJECTION	0.68 %
INTRAVENOUS	POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	68 MG/VIAL
INTRAVENOUS	POWDER, FOR RECONSTITUTION	2.72 %
INTRAVENOUS	SOLUTION, INJECTION	0.085 %
INTRAVESICAL	SOLUTION, INJECTION	2.92 %
IV(INFUSION)	INJECTION	68 MG/1VIAL
IV(INFUSION)	SOLUTION, INJECTION	1.36 %
NASAL	SOLUTION	0.071 %
NASAL	SPRAY	0.14 %
NERVE BLOCK	INJECTION	2.72 %
OPHTHALMIC	SOLUTION	0.2 %
OPHTHALMIC	SUSPENSION	0.44 %
ORAL	CAPSULE, ENTERIC COATED PELLETS	17 MG
ORAL	EMULSION	NA
ORAL	SOLUTION	25 MG/5ML
ORAL	SOLUTION, SYRUP	4.75 MG/1ML
ORAL	SUSPENSION	50 MG/5ML
ORAL	SYRUP	13.66 MG/5ML
ORAL	TABLET	25 MG
ORAL	TABLET, SUSTAINED ACTION	4 MG
SUBCUTANEOUS	INJECTABLE	0.27 %
SUBCUTANEOUS	INJECTION	0.27 %
SUBCUTANEOUS	POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	0.12 %